About this trial
The focus of this proposal is on overweight (25\>BMI\<30 kg/m2) subjects, as these individuals exhibit a high risk of becoming obese and/or developing metabolic diseases. We hypothesize that in some overweight individuals there is a "metabolic program" in skeletal muscle which predisposes them to the development of obesity. Findings may lead to clinical screening tools for determining risk for obesity in non-obese individuals and targeting this group for prevention.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18-50 years old
BMI of 25 - 30 kg/m2
BMI > 40kg/m2
Lactate levels in top and lower 25%
Disqualifiers
Pregnant women
Mentally disabled
Prisoners
Smokers
Trial population
High oxidizers Low oxidizers Obese
Trial design
Cohort
Prospective
Treatments tested in this trial
Weight loss surgery
Procedure/SurgerySeverely obese women (BMI \>40) undergo sleeve gastrectomy
Treatment groups
Trial outcomes
Primary outcomes
Carbohydrate/fat oxidation (RER) in the fasting condition.
RER will be measured from indirect calorimetry
Muscle oxygen consumption (substrate oxidation) in the fasting condition.
Muscle oxygen consumption will be measured by near-infrared spectroscopy (NIRS)
Muscle lactate release in the fasting condition.
Muscle lactate release will be measured by microdialysis
Change in Carbohydrate/fat oxidation (RER) in response to glucose + insulin (metabolic flexibility)
Indirect calorimetry during glucose clamp
Secondary outcomes
Insulin sensitivity (clamp M value).
Measured during glucose clamp.
Endogenous glucose production in the fasting condition.
Measured with isotopically labeled glucose
Sponsors and contacts
Click on the lead sponsor to view all of their trials.